Efficacy and safety of statins for patients with chronic kidney disease

Efficacy and safety of statins for patients with chronic kidney disease - Kidney protection of statins

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005812

Enrollment

100

Registered

2011-06-20

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

Statin(A-group) Statin (B-group)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: LDL-C > 120mg/dL Urinary albumin/Cr ratio > 30 mg/gCr

Exclusion criteria

Exclusion criteria: Patients treated with dialysis therapy LDL cholesterol < 120 mg/dL

Design outcomes

Primary

Measure	Time frame
Kidney function (serum creatinine, estimated glomerular filtration rate, cystatin C), Urinary albumin or protein, Urinary 8-OHdG and L-FABP, Serum lipid profile	—

Countries

Japan

Contacts

Public ContactMasanori Abe

Nihon University School of Medicine Nephrology, Hypertension and Endocrinology

mabe@med.nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026